Your browser doesn't support javascript.
loading
Drugs in preclinical to phase II clinical development for the treatment of erectile dysfunction.
Smith-Harrison, Li; Starke, Nathan R; Smith, Ryan P; Kovac, Jason R.
Affiliation
  • Smith-Harrison L; a Department of Urology , University of Virginia , Charlottesville , VA , USA.
  • Starke NR; a Department of Urology , University of Virginia , Charlottesville , VA , USA.
  • Smith RP; a Department of Urology , University of Virginia , Charlottesville , VA , USA.
  • Kovac JR; b Men's Health Center , Urology of Indiana , Indianapolis , IN , USA.
Expert Opin Investig Drugs ; 26(6): 669-675, 2017 Jun.
Article in En | MEDLINE | ID: mdl-28460540
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Design / Drugs, Investigational / Erectile Dysfunction Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limits: Animals / Humans / Male Language: En Journal: Expert Opin Investig Drugs Journal subject: TERAPIA POR MEDICAMENTOS Year: 2017 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Design / Drugs, Investigational / Erectile Dysfunction Type of study: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limits: Animals / Humans / Male Language: En Journal: Expert Opin Investig Drugs Journal subject: TERAPIA POR MEDICAMENTOS Year: 2017 Document type: Article Affiliation country: United States Country of publication: United kingdom